Clinical Trials Browser

INDUSTRY × Metastatic Hormone Refractory Prostate Cancer × Clear all

NCT00766324 2014-05-28

PHA-739358 for Treatment of Hormone Refractory Prostate Cancer

Phase 2 Completed

Metastatic Hormone Refractory Prostate Cancer